319 related articles for article (PubMed ID: 32436333)
21. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
22. miR-124-3p availability is antagonized by LncRNA-MALAT1 for Slug-induced tumor metastasis in hepatocellular carcinoma.
Cui RJ; Fan JL; Lin YC; Pan YJ; Liu C; Wan JH; Wang W; Jiang ZY; Zheng XL; Tang JB; Yu XG
Cancer Med; 2019 Oct; 8(14):6358-6369. PubMed ID: 31466138
[TBL] [Abstract][Full Text] [Related]
23. Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A.
Cui S; Zhang K; Li C; Chen J; Pan Y; Feng B; Lu L; Zhu Z; Wang R; Chen L
Oncotarget; 2016 Nov; 7(47):78009-78028. PubMed ID: 27793005
[TBL] [Abstract][Full Text] [Related]
24. DANCR promotes HCC progression and regulates EMT by sponging miR-27a-3p via ROCK1/LIMK1/COFILIN1 pathway.
Guo D; Li Y; Chen Y; Zhang D; Wang X; Lu G; Ren M; Lu X; He S
Cell Prolif; 2019 Jul; 52(4):e12628. PubMed ID: 31038266
[TBL] [Abstract][Full Text] [Related]
25. Tumour-derived exosomal lncRNA SNHG16 induces telocytes to promote metastasis of hepatocellular carcinoma via the miR-942-3p/MMP9 axis.
Xu Y; Luan G; Li Z; Liu Z; Qin G; Chu Y
Cell Oncol (Dordr); 2023 Apr; 46(2):251-264. PubMed ID: 36434360
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.
Wang W; Lin H; Zhou L; Zhu Q; Gao S; Xie H; Liu Z; Xu Z; Wei J; Huang X; Zheng S
Eur J Surg Oncol; 2014 Nov; 40(11):1586-94. PubMed ID: 24290372
[TBL] [Abstract][Full Text] [Related]
27. Reciprocal activation between ATPase inhibitory factor 1 and NF-κB drives hepatocellular carcinoma angiogenesis and metastasis.
Song R; Song H; Liang Y; Yin D; Zhang H; Zheng T; Wang J; Lu Z; Song X; Pei T; Qin Y; Li Y; Xie C; Sun B; Shi H; Li S; Meng X; Yang G; Pan S; Zhu J; Qi S; Jiang H; Zhang Z; Liu L
Hepatology; 2014 Nov; 60(5):1659-73. PubMed ID: 25042864
[TBL] [Abstract][Full Text] [Related]
28. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC.
Zhao N; Sun H; Sun B; Zhu D; Zhao X; Wang Y; Gu Q; Dong X; Liu F; Zhang Y; Li X
Sci Rep; 2016 Mar; 6():23091. PubMed ID: 26980408
[TBL] [Abstract][Full Text] [Related]
29. LncRNA ANCR promotes hepatocellular carcinoma metastasis through upregulating HNRNPA1 expression.
Wen Z; Lian L; Ding H; Hu Y; Xiao Z; Xiong K; Yang Q
RNA Biol; 2020 Mar; 17(3):381-394. PubMed ID: 31868085
[TBL] [Abstract][Full Text] [Related]
30. LINC01410-miR-532-NCF2-NF-kB feedback loop promotes gastric cancer angiogenesis and metastasis.
Zhang JX; Chen ZH; Chen DL; Tian XP; Wang CY; Zhou ZW; Gao Y; Xu Y; Chen C; Zheng ZS; Weng HW; Ye S; Kuang M; Xie D; Peng S
Oncogene; 2018 May; 37(20):2660-2675. PubMed ID: 29483646
[TBL] [Abstract][Full Text] [Related]
31. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma.
Yang B; Feng X; Liu H; Tong R; Wu J; Li C; Yu H; Chen Y; Cheng Q; Chen J; Cai X; Wu W; Lu Y; Hu J; Liang K; Lv Z; Wu J; Zheng S
Oncogene; 2020 Oct; 39(42):6529-6543. PubMed ID: 32917956
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
He Y; He X
Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
[TBL] [Abstract][Full Text] [Related]
33. Small regulatory polypeptide of amino acid response negatively relates to poor prognosis and controls hepatocellular carcinoma progression via regulating microRNA-5581-3p/human cardiolipin synthase 1.
Yin J; Liu Q; Chen C; Liu W
J Cell Physiol; 2019 Aug; 234(10):17589-17599. PubMed ID: 30825207
[TBL] [Abstract][Full Text] [Related]
34. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
Chen S; Wang L; Yao B; Liu Q; Guo C
Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
[TBL] [Abstract][Full Text] [Related]
35. LncRNA SNHG16 promotes cell proliferation through miR-302a-3p/FGF19 axis in hepatocellular carcinoma.
Li W; Xu W; Song JS; Wu T; Wang WX
Neoplasma; 2019 May; 66(3):397-404. PubMed ID: 30784284
[TBL] [Abstract][Full Text] [Related]
36. A Positive Feedback Loop of AKR1C3-Mediated Activation of NF-κB and STAT3 Facilitates Proliferation and Metastasis in Hepatocellular Carcinoma.
Zhou Q; Tian W; Jiang Z; Huang T; Ge C; Liu T; Zhao F; Chen T; Cui Y; Li H; Yao M; Li J; Tian H
Cancer Res; 2021 Mar; 81(5):1361-1374. PubMed ID: 33361392
[TBL] [Abstract][Full Text] [Related]
37. Long intergenic noncoding RNA SNHG16 interacts with miR-195 to promote proliferation, invasion and tumorigenesis in hepatocellular carcinoma.
Xie X; Xu X; Sun C; Yu Z
Exp Cell Res; 2019 Oct; 383(1):111501. PubMed ID: 31306653
[TBL] [Abstract][Full Text] [Related]
38. miR-187-3p inhibits the metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting S100A4.
Dou C; Liu Z; Xu M; Jia Y; Wang Y; Li Q; Yang W; Zheng X; Tu K; Liu Q
Cancer Lett; 2016 Oct; 381(2):380-90. PubMed ID: 27544906
[TBL] [Abstract][Full Text] [Related]
39. LncRNA SNHG3 Promotes Hepatocellular Tumorigenesis by Targeting miR-326.
Zhao Q; Wu C; Wang J; Li X; Fan Y; Gao S; Wang K
Tohoku J Exp Med; 2019 Sep; 249(1):43-56. PubMed ID: 31548493
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA CASC2 regulates hepatocellular carcinoma cell oncogenesis through miR-362-5p/Nf-κB axis.
Zhao L; Zhang Y; Zhang Y
J Cell Physiol; 2018 Oct; 233(10):6661-6670. PubMed ID: 29319182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
